Optimal Human Dose for GII.2 Norovirus (Snow Mountain) Challenge Studies

NCT02473224 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

44

Enrollment

NIH

Sponsor class

Conditions

Gastroenteritis Norovirus

Interventions

BIOLOGICAL: Norovirus GII.2 Challenge
OTHER: Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)